Patients with Pulmonary Metastases from Head and Neck Cancer Benefit from Pulmonary Metastasectomy, A Systematic Review

Background and Objectives: The incidence of distant metastases in patients with head and neck cancer (HNC) is approximately 10%. Pulmonary metastases are the most frequent distant location, with an incidence of 70–85%. The standard treatment options are chemo-, immuno- and radiotherapy. Despite a be...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlachtenberger, Georg, Doerr, Fabian, Menghesha, Hruy, Lauinger, Patrick, Wolber, Philipp, Sabashnikov, Anton, Popov, Aron-Frederik, Macherey-Meyer, Sascha, Bennink, Gerardus, Klussmann, Jens P., Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Mathias B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332790/
https://www.ncbi.nlm.nih.gov/pubmed/35893115
http://dx.doi.org/10.3390/medicina58081000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332790/
https://www.ncbi.nlm.nih.gov/pubmed/35893115
http://dx.doi.org/10.3390/medicina58081000

Ejemplares similares